Mesoblast (MESO) Long-Term Deferred Tax (2017 - 2021)
Mesoblast's (MESO) quarterly Long-Term Deferred Tax came in at $80.2 million in Q2 2021, up 1.35% year-on-year from $79.1 million in Q2 2020, and up 1.35% quarter-over-quarter from $79.1 million in Q2 2020.
Mesoblast (MESO) Long-Term Deferred Tax (2017 - 2021) Analysis & Trends
Mesoblast has disclosed Long-Term Deferred Tax across 5 years of filings, most recently posting $80.2 million for Q2 2021.
- Long-Term Deferred Tax for Q2 2021 came in at $80.2 million, up 1.35% year-over-year; the trailing twelve-month figure through Jun 2021 was $80.2 million (up 1.35% YoY), and the FY2021 annual result was $80.2 million, up 1.35% from the prior year.
- Long-Term Deferred Tax came in at $80.2 million for Q2 2021 at Mesoblast, up from $79.1 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $80.2 million in Q2 2021 to a low of $56.6 million in Q2 2018.
- The 5-year median for Long-Term Deferred Tax is $78.2 million (2017), against an average of $71.9 million.
- Across the five-year window, Long-Term Deferred Tax dropped 27.68% in 2018 and grew 20.89% in 2020, its largest moves.
- Mesoblast's Long-Term Deferred Tax stood at $78.2 million in 2017, then slipped by 27.68% to $56.6 million in 2018, then climbed by 15.65% to $65.4 million in 2019, then climbed by 20.89% to $79.1 million in 2020, then advanced by 1.35% to $80.2 million in 2021.
- The last three Long-Term Deferred Tax figures came in at $80.2 million (Q2 2021), $79.1 million (Q2 2020), and $65.4 million (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 80.16 Mn |
| Jun 30, 2020 | 79.10 Mn |
| Jun 30, 2019 | 65.43 Mn |
| Jun 30, 2018 | 56.57 Mn |
| Jun 30, 2017 | 78.23 Mn |